1. Home
  2. CNA vs ARWR Comparison

CNA vs ARWR Comparison

Compare CNA & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNA Financial Corporation

CNA

CNA Financial Corporation

HOLD

Current Price

$52.49

Market Cap

12.0B

Sector

Finance

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$86.31

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNA
ARWR
Founded
1853
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.0B
10.2B
IPO Year
1994
2009

Fundamental Metrics

Financial Performance
Metric
CNA
ARWR
Price
$52.49
$86.31
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$83.40
AVG Volume (30 Days)
480.1K
2.2M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
8.20%
N/A
EPS Growth
33.24
99.80
EPS
1.95
N/A
Revenue
$14,989,000,000.00
$16,142,321.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$27.16
N/A
Revenue Growth
5.04
N/A
52 Week Low
$41.53
$15.01
52 Week High
$55.71
$95.49

Technical Indicators

Market Signals
Indicator
CNA
ARWR
Relative Strength Index (RSI) 53.40 58.70
Support Level $44.63 $70.03
Resistance Level $52.86 $87.83
Average True Range (ATR) 1.32 4.04
MACD -0.30 0.70
Stochastic Oscillator 22.40 69.72

Price Performance

Historical Comparison
CNA
ARWR

About CNA CNA Financial Corporation

CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business, and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property, and casualty products to small businesses and medium-scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are generated from the Specialty and Commercial segment of the business.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Share on Social Networks: